ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation

ClinicalTrials.gov ID: NCT00122161

Public ClinicalTrials.gov record NCT00122161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00122161
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
US Department of Veterans Affairs
Federal
Enrollment
190 participants

Conditions and interventions

Conditions

Interventions

  • ATHENA Decision Support System, An Automated Clinical Decision Support System for Health Care Providers Behavioral
  • Profiling performance Behavioral

Behavioral

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Aug 31, 2005
Last update posted
Apr 6, 2015

Ends 2005

United States locations

U.S. sites
3
U.S. states
2
U.S. cities
3
Facility City State ZIP Site status
VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California 94304-1290
San Francisco VA Medical Center, San Francisco, CA San Francisco California 94121
Durham VA Medical Center, Durham, NC Durham North Carolina 27705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00122161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 6, 2015 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00122161 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →